Achievements
-
.10compounds
in clinical development with the potential to become medicines for children, pregnant women and people suffering from drug-resistant malaria
-
.USD 1= USD 3.5
of investment impact thanks to direct and in-kind support from partners
-
.128mvials
of injectable artesunate for severe malaria delivered since 2010, saving the lives of an estimated 840,000 additional vulnerable children compared with quinine treatment
Defeating malaria together
Featured resources
-
The life-saving benefits of pre-referral management
Apr 2019 -
Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum
Apr 2019 -
African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker
Apr 2019
